vs
Side-by-side financial comparison of SBC Medical Group Holdings Inc (SBC) and WEST BANCORPORATION INC (WTBA). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $26.9M, roughly 1.5× WEST BANCORPORATION INC). WEST BANCORPORATION INC runs the higher net margin — 39.2% vs 35.9%, a 3.4% gap on every dollar of revenue. On growth, WEST BANCORPORATION INC posted the faster year-over-year revenue change (16.6% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $12.4M). Over the past eight quarters, WEST BANCORPORATION INC's revenue compounded faster (17.3% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
West Bancorporation Inc. is a regional financial holding company headquartered in the U.S. Midwest, primarily serving markets across Iowa and Minnesota. It provides a full suite of personal and commercial banking services, including deposit accounts, mortgage loans, business lending, and wealth management solutions for individual consumers, small-to-medium enterprises, and local organizational clients.
SBC vs WTBA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $39.6M | $26.9M |
| Net Profit | $14.2M | $10.6M |
| Gross Margin | 73.1% | — |
| Operating Margin | 32.5% | 50.0% |
| Net Margin | 35.9% | 39.2% |
| Revenue YoY | -10.9% | 16.6% |
| Net Profit YoY | 117.2% | 34.8% |
| EPS (diluted) | $0.15 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $26.9M | ||
| Q4 25 | $39.6M | $24.2M | ||
| Q3 25 | $43.4M | $25.0M | ||
| Q2 25 | $43.4M | $23.8M | ||
| Q1 25 | $47.3M | $23.1M | ||
| Q4 24 | $44.4M | $20.9M | ||
| Q3 24 | $53.1M | $20.3M | ||
| Q2 24 | $53.1M | $19.6M |
| Q1 26 | — | $10.6M | ||
| Q4 25 | $14.2M | $7.4M | ||
| Q3 25 | $12.8M | $9.3M | ||
| Q2 25 | $2.5M | $8.0M | ||
| Q1 25 | $21.5M | $7.8M | ||
| Q4 24 | $6.5M | $7.1M | ||
| Q3 24 | $2.8M | $6.0M | ||
| Q2 24 | $18.5M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | 73.1% | — | ||
| Q3 25 | 70.6% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 79.7% | — | ||
| Q4 24 | 76.3% | — | ||
| Q3 24 | 81.5% | — | ||
| Q2 24 | 74.2% | — |
| Q1 26 | — | 50.0% | ||
| Q4 25 | 32.5% | 39.6% | ||
| Q3 25 | 36.6% | 45.8% | ||
| Q2 25 | 33.6% | 43.4% | ||
| Q1 25 | 51.1% | 43.4% | ||
| Q4 24 | 10.6% | 30.9% | ||
| Q3 24 | 26.1% | 36.6% | ||
| Q2 24 | 51.4% | 32.6% |
| Q1 26 | — | 39.2% | ||
| Q4 25 | 35.9% | 30.7% | ||
| Q3 25 | 29.6% | 37.3% | ||
| Q2 25 | 5.7% | 33.5% | ||
| Q1 25 | 45.4% | 34.0% | ||
| Q4 24 | 14.7% | 34.0% | ||
| Q3 24 | 5.3% | 29.3% | ||
| Q2 24 | 34.8% | 26.5% |
| Q1 26 | — | $0.61 | ||
| Q4 25 | $0.15 | $0.44 | ||
| Q3 25 | $0.12 | $0.55 | ||
| Q2 25 | $0.02 | $0.47 | ||
| Q1 25 | $0.21 | $0.46 | ||
| Q4 24 | $0.05 | $0.41 | ||
| Q3 24 | $0.03 | $0.35 | ||
| Q2 24 | $0.20 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.1M | $362.0M |
| Total DebtLower is stronger | $42.8M | — |
| Stockholders' EquityBook value | $248.3M | $270.7M |
| Total Assets | $380.4M | $4.0B |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $362.0M | ||
| Q4 25 | $164.1M | $471.1M | ||
| Q3 25 | $127.4M | $232.9M | ||
| Q2 25 | $152.7M | $345.2M | ||
| Q1 25 | $132.1M | — | ||
| Q4 24 | $125.0M | $243.5M | ||
| Q3 24 | $137.4M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $42.8M | — | ||
| Q3 25 | $21.1M | — | ||
| Q2 25 | $7.1M | — | ||
| Q1 25 | $6.9M | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $823.2K | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $270.7M | ||
| Q4 25 | $248.3M | $266.0M | ||
| Q3 25 | $248.0M | $255.1M | ||
| Q2 25 | $244.6M | $240.9M | ||
| Q1 25 | $226.4M | $237.9M | ||
| Q4 24 | $195.1M | $227.9M | ||
| Q3 24 | $205.0M | $235.4M | ||
| Q2 24 | $8.8M | $223.9M |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $380.4M | $4.1B | ||
| Q3 25 | $321.4M | $4.0B | ||
| Q2 25 | $315.3M | $4.1B | ||
| Q1 25 | $284.6M | $4.0B | ||
| Q4 24 | $266.1M | $4.0B | ||
| Q3 24 | $296.5M | $4.0B | ||
| Q2 24 | $19.5M | $4.0B |
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $12.9M |
| Free Cash FlowOCF − Capex | $51.2M | $12.4M |
| FCF MarginFCF / Revenue | 129.3% | 46.0% |
| Capex IntensityCapex / Revenue | 2.0% | 1.8% |
| Cash ConversionOCF / Net Profit | 3.66× | 1.22× |
| TTM Free Cash FlowTrailing 4 quarters | $23.3M | $79.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $12.9M | ||
| Q4 25 | $52.0M | $46.5M | ||
| Q3 25 | $-20.9M | $11.4M | ||
| Q2 25 | $-8.3M | $13.5M | ||
| Q1 25 | $1.9M | $9.7M | ||
| Q4 24 | $-7.3M | $39.8M | ||
| Q3 24 | $5.0M | $12.9M | ||
| Q2 24 | $19.2M | $10.0M |
| Q1 26 | — | $12.4M | ||
| Q4 25 | $51.2M | $43.2M | ||
| Q3 25 | $-20.9M | $10.8M | ||
| Q2 25 | $-8.6M | $12.8M | ||
| Q1 25 | $1.7M | $8.3M | ||
| Q4 24 | $-7.9M | $13.7M | ||
| Q3 24 | $4.6M | $7.0M | ||
| Q2 24 | $18.3M | $2.7M |
| Q1 26 | — | 46.0% | ||
| Q4 25 | 129.3% | 178.3% | ||
| Q3 25 | -48.3% | 43.0% | ||
| Q2 25 | -19.9% | 53.6% | ||
| Q1 25 | 3.5% | 35.7% | ||
| Q4 24 | -17.8% | 65.6% | ||
| Q3 24 | 8.7% | 34.2% | ||
| Q2 24 | 34.5% | 14.0% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | 2.0% | 13.7% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 0.7% | 3.2% | ||
| Q1 25 | 0.5% | 6.5% | ||
| Q4 24 | 1.3% | 125.3% | ||
| Q3 24 | 0.8% | 29.4% | ||
| Q2 24 | 1.6% | 37.1% |
| Q1 26 | — | 1.22× | ||
| Q4 25 | 3.66× | 6.26× | ||
| Q3 25 | -1.63× | 1.23× | ||
| Q2 25 | -3.39× | 1.70× | ||
| Q1 25 | 0.09× | 1.24× | ||
| Q4 24 | -1.12× | 5.61× | ||
| Q3 24 | 1.77× | 2.17× | ||
| Q2 24 | 1.04× | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
WTBA
Segment breakdown not available.
